We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$280B
AUM Growth
+$58B
Cap. Flow
-$9.91B
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.38%
Holding
11,014
New
1,506
Increased
4,384
Reduced
3,586
Closed
1,324

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$861M
2
AAPL icon
Apple
AAPL
+$417M
3
JPM icon
JPMorgan Chase
JPM
+$350M
4
TMUS icon
T-Mobile US
TMUS
+$337M
5
AON icon
Aon
AON
+$296M

Sector Composition

Rank Sector Weight
1 Healthcare 3.4%
2 Technology 3.32%
3 Consumer Discretionary 2.87%
4 Financials 2.84%
5 Industrials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTBL
10476
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
-306
Closed -$14K
ORAN
10477
CALL
DELISTED
Orange
ORAN
-21,200
Closed -$256K
SEEL
10478
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-9
Closed -$17K
EGRX
10479
PUT
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-5,600
Closed -$258K
ASXC
10480
DELISTED
Asensus Surgical, Inc.
ASXC
-90,840
Closed -$43.8K
FNCB
10481
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
-12,304
Closed -$85K
MODN
10482
DELISTED
MODEL N, INC.
MODN
-194,089
Closed -$5.65M
AVGR
10483
DELISTED
Avinger, Inc. Common Stock
AVGR
-76
Closed -$9K
CEM
10484
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
-9,472
Closed -$87K
NTG
10485
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
-19,282
Closed -$165K
TAST
10486
DELISTED
Carrols Restaurant Group, Inc.
TAST
-33,680
Closed -$127K
AEL
10487
DELISTED
American Equity Investment Life Holding Company
AEL
-93,101
Closed -$1.94M
FUV
10488
DELISTED
Arcimoto, Inc. Common Stock
FUV
-631
Closed -$15K
MDC
10489
DELISTED
M.D.C. Holdings, Inc.
MDC
-115,458
Closed -$3.19M
SCTL
10490
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
-79,706
Closed -$493K
CCLP
10491
PUT
DELISTED
CSI Compressco LP
CCLP
-17,900
Closed -$12K
NGE
10492
DELISTED
Global X MSCI Nigeria ETF
NGE
-27,805
Closed -$229K
TGH
10493
DELISTED
Textainer Group Holdings limited
TGH
-70,188
Closed -$575K
GOEV
10494
DELISTED
Canoo Inc. Class A Common Stock
GOEV
-38
Closed -$177K
NEPT
10495
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
-42
Closed -$141K
LBC
10496
DELISTED
Luther Burbank Corporation Common Stock
LBC
-36,186
Closed -$332K
YPS
10497
DELISTED
Arrow Reverse Cap 500 ETF
YPS
-28,952
Closed -$349K
PGAL
10498
DELISTED
Global X MSCI Portugal ETF
PGAL
-56,433
Closed -$464K
DMK
10499
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-1,374
Closed -$34K
SALM
10500
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
-17,781
Closed -$16K

Similar funds

Citadel Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.

  • Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
  • Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
  • Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
  • Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
  • Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
  • Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.